NBSE

NeuBase Therapeutics, Inc.

Total Trades

7

Buys

5

Sells

2

Largest Trade

$100K–$500K

Insiders

4

Institutional Funds

1

Inst. Value

N/A

Activist Filings

6

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Symetryx Corp10% OwnerSELL$100K–$500K282K$1.33Sep 18, 2023
Symetryx Corp10% OwnerSELL$100K–$500K207K$1.63Sep 11, 2023
Symetryx Corp10% OwnerBUY$50K–$100K61K$0.98Sep 7, 2023
Mann William RolandCOOBUY$1K–$15K6K$1.92Apr 1, 2022
Branning Todd P.CFOBUY$15K–$50K10K$1.81Mar 21, 2022
Branning Todd P.CFOBUY$15K–$50K20K$1.68Mar 18, 2022
RICHMAN ERIC IDirectorBUY$1K–$15K4K$1.64Mar 8, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 1 funds holding

FundShares
HUNTINGTON NATIONAL BANK1

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Greenlight Capital, Inc.

SC 13G/A · Feb 14, 2024

1.7%

64K shares

Symetryx Corporation

SC 13D/A · Sep 20, 2023

0.0%

0 shares

Symetryx Corporation

SC 13D/A · Sep 14, 2023

9.1%

473K shares

Symetryx Corporation

SC 13D · Aug 31, 2023

13.8%

428K shares

Kershner Trading Americas, LLC

SC 13G/A · Jan 27, 2023

4.5%

1.5M shares

Greenlight Capital, Inc.

SC 13G/A · Feb 14, 2022

3.9%

1.3M shares